Valuation Nipro Corporation

Stocks

Market Closed - Japan Exchange 09:30:00 24/09/2026 +03			5-day change	1st Jan Change
1,441.00 ^JPY	-0.14%		-1.57%	-2.44%

09-21	Nipro Corporation(TSE:8086) dropped from FTSE All-World Index	CI
07-30	Nipro Corporation Receives Fda 510(K) Clearance for Elisio-Hx Dialyzer and Introduces Hds to the United States	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	167,011	166,195	199,874	221,565	253,125	239,515	-	-
Change	-	-0.49%	20.26%	10.85%	14.24%	-5.38%	-	-
Enterprise Value (EV) ¹	636,521	672,257	730,303	745,971	796,341	740,426	728,725	703,275
Change	-	5.61%	8.63%	2.15%	6.75%	-7.02%	-1.58%	-3.49%
P/E	12.4x	36.3x	18x	43.3x	18.7x	14.9x	11.3x	9.19x
PBR	0.9x	0.81x	0.86x	0.88x	0.92x	0.84x	0.79x	0.74x
PEG	-	-0.6x	0x	-0.8x	0x	0.9x	0.4x	0.4x
Capitalization / Revenue	0.34x	0.3x	0.34x	0.34x	0.38x	0.34x	0.33x	0.31x
EV / Revenue	1.29x	1.23x	1.24x	1.16x	1.21x	1.06x	1x	0.92x
EV / EBITDA	9.09x	10.1x	8.99x	8.09x	7.86x	7.05x	6.38x	5.67x
EV / EBIT	26.7x	37.9x	32.7x	28x	21.2x	18.5x	15.8x	13.5x
EV / FCF	-62.3x	-11x	-24x	-218x	-48.4x	35.7x	42.8x	30.2x
FCF Yield	-1.61%	-9.12%	-4.17%	-0.46%	-2.06%	2.8%	2.34%	3.31%
Dividend per Share ²	27	22	25	25	29	36	45	56
Rate of return	2.64%	2.16%	2.04%	1.84%	1.87%	2.5%	3.12%	3.89%
EPS ²	82.5	28.05	68.12	31.36	82.8	96.9	128	156.9
Distribution rate	32.7%	78.4%	36.7%	79.7%	35%	37.2%	35.2%	35.7%
Net sales ¹	494,789	545,199	586,785	644,586	660,538	701,066	728,812	760,969
EBITDA ¹	70,046	66,472	81,207	92,246	101,361	105,023	114,303	124,083
EBIT ¹	23,882	17,729	22,335	26,598	37,624	39,981	46,073	52,136
Net income ¹	13,455	4,574	11,109	5,113	13,504	15,393	19,953	24,140
Net Debt ¹	469,510	506,062	530,429	524,406	543,216	500,910	489,210	463,760
Reference price ²	1,024.00	1,019.00	1,225.50	1,358.50	1,552.00	1,441.00	1,441.00	1,441.00
Nbr of stocks (in thousands)	163,097	163,097	163,096	163,096	163,096	166,215	-	-
Announcement Date	5/11/22 A	5/11/23 A	5/10/24 A	5/12/25 A	5/12/26 A	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NIPRO CORPORATION	14.89x	1.06x	7.05x	2.49%	1.51B
ABBOTT LABORATORIES	29.32x	4.04x	15.63x	2.48%	179B
MEDTRONIC PLC	18.89x	3.46x	12.38x	3.15%	114B
CENCORA, INC.	17.1x	0.2x	12.53x	0.76%	59.59B
BECTON, DICKINSON AND COMPANY	35.17x	3.41x	11.66x	2.15%	49.72B
HOYA CORPORATION	27.56x	6.78x	17.54x	1.45%	47.75B
DEXCOM, INC.	35.17x	6.18x	19.42x	-.--%	33.11B
MEDLINE INC.	44.28x	1.29x	11.93x	0.21%	30.09B
WEST PHARMACEUTICAL SERVICES, INC.	43.83x	7.69x	27.59x	0.24%	26.45B
SARTORIUS STEDIM BIOTECH	52.43x	7.04x	22.63x	0.4%	22.79B
Average	31.87x	4.12x	15.84x	1.34%	56.43B
Weighted average by Cap.	29.00x	3.96x	15.30x	1.87%